SUMMARY Intestinal permeability to probe molecules has been shown to correlate closely with the presence or absence of villous atrophy in a jejunal biopsy. The purpose of this study was to establish if there exist groups of patients with functional derangement of intestinal permeability but normal histopathology of the small bowel mucosa. In 135 patients a cellobiose/mannitol permeability test was performed at the same time as jejunal biopsy. Diagnosis included coeliac disease, Crohn's disease, irritable bowel syndrome, idiopathic diarrhoea, self diagnosed food allergy, atopic eczema and postinfectious malabsorption. The value of the cellobiose/mannitol test in identifying patients with abnormal jejunal biopsy histopathology was confirmed. The permeability test was abnormal in all 28 patients with partial or subtotal villous atrophy, and also in all 10 in whom there was a high intraepithelial lymphocyte count despite normal villi and crypts. Functional abnormality of the small intestine has not previously been reported in patients with this jejunal biopsy abnormality. Abnormalities of permeability were also found in patients with idiopathic diarrhoea, folate deficiency, postinfectious or traveller's diarrhoea, small bowel Crohn's disease, and atopic eczema. These results show that sugar permeability tests have more potential in clinical investigation than merely serving as screening tests before jejunal biopsy. There are groups of patients without morphological changes in the small bowel in whom intestinal permeability is abnormal.
In the initial clinical assessments of these permeability tests, several patients with non-coeliac gastrointestinal disease6 7 or with atopic eczema8 have been described, in whom permeability ratios are abnormal. Thus there may exist groups of patients with functional derangement of intestinal permeability, in which the bowel is 'leaky' to large probes, even though histopathology is normal. Clearly, this could provide an entirely new approach to investigation of disorders of the jejunum although it will remain essential to interpret the results of such permeability tests in the knowledge of intestinal histopathology. We have performed, simultaneously, jejunal biopsy and a cellobiose/ mannitol sugar permeability test in order to determine if indeed these tests are complementary. One hundred and thirty five patients were investigated, all of whom were undergoing investigation of diarrhoeal disease, malabsorption or possible food allergy. The results show not only that the sugar permeability test will predict all patients with abnormal jejunal histopathology, but also that there exist a group of distinct clinical and pathological entities, where sugar permeability is abnormal despite unequivocally normal jejunal biopsy histopathology.
Methods

PATIENTS AND VOLUNTEERS
Fifteen normal volunteers who had not had jejunal biopsy (healthy laboratory and medical staff) age range 21-42 years, were used to establish a provisional normal range for the test. As the test. solution contained lactose, a further five doctors, all clinically lactose malabsorbers (assessed by the breath hydrogen test after a lactose load) also participated in the test.
BIOPSIED PATIENTS
Patients undergoing jejunal biopsy for conventional clinical indications -diarrhoea, suspected malabsorption, follow up of treated coeliac disease and possible food allergic disease -comprised the study group. There were 135 patients, an unselected sequential series of patients, whose ages ranged from 14-75 years. After the study had been completed, case notes were reviewed retrospectively and a final diagnosis made on the basis of all the clinical information including the result of the jejunal biopsy histopathology and disaccharidase assays but without knowledge of the result of the sugar permeability test. The final diagnoses are listed in Table 1 .
INVESTIGATIVE PROCEDURES
The procedures were performed mainly in out patients, who attend a clinical investigation suite Of the patients in whom no significant jejunal disease was present, all but two had normal C/M ratios. Thus these comprised the nine normal subjects, 15 patients with irritable bowel syndrome and nine with unsubstantiated, self-diagnosed food Figure. C/M ratio was abnormal in all coeliacs ingesting a normal diet; those patients with entirely normal jejunal histopathology on a gluten free diet had normal C/M tests, and all of those with abnormal histopathology despite prescribed gluten free diet, had an abnormal ratio. On the other hand abnormal ratios were found in five of 10 patients with idiopathic diarrhoea, all five folate deficient individuals, one of four patients with postinfectious or traveller's diarrhoea, five of seven with small bowel Crohn's disease and four of 13 with atopic eczema, despite the presence of normal villi in the jejunal biopsy. Biopsies from the patients with idiopathic diarrhoea, atopic eczema and folate deficiency had normal disaccharidase activities though three of these patients had a high intraepithelial lymphocyte count. In the group classified as 'miscellaneous' C/M ratios ranged from 0-01 to 0-052. Abnormal results were obtained in patients with the following diagnoses: systemic lupus erythematosus, primary biliary cirrhosis, diarrhoea after gastric surgery, and short stature (a borderline result at 0 038).
Discussion
This prospective study confirms and extends other reports on the use of permeability tests in the investigation of patients with small bowel disease. The cellobiose/mannitol permeability test has a high patient acceptability and we have found that, by The difference between the two groups was only 0*03%, equivalent to 1.5 mg glucose or 3 mg lactose.
That is equivalent to 0-015% of the ingested dose, rather less than the 0-09% excretion reported by Menzies2 who used paper chromatography, and studied lactose excretion over 10 hours. Furthermore, we have found no difference in per cent cellobiose excretion when normal lactase deficient subjects have been compared with other normal subjects.
Thus the results of the study indicated negligible interference from lactose in the enzymatic procedure for the measurement of cellobiose. A sugar solution containing both lactose and sucrose is distinctly more palatable than one containing sucrose alone. For these reasons, and in order to introduce as few variables as possible between our test and those previously reported in the literature, we have retained as the standard test solution, a drink which contains cellobiose, mannitol, sucrose, and lactose.
Although the mechanism by which these sugars penetrate the epithelium is still hypothetical, the existence of at least two different sets of pores has previously been postulated,12 (0-4 nM diameter for mannitol, 0*52 nM diameter for cellobiose). In patients with untreated coeliac disease and villous atrophy, reduction in mannitol recovery is thought to be because of a reduction of pores available for diffusion as a consequence of low surface area, whereas the increased permeability to larger molecules may be via epithelial discontinuities (altered tight junctions, cell extrusion zones). The present study confirms that abnormal results are obtained in all patients with partial or subtotal villus atrophy in a jejunal biopsy, not only in coeliac disease but also in patients with postinfectious malabsorption.
Intraepithelial 
Method
The following were incubated at 37°C with 0.2 ml ,3-glucosidase reagent: 0-2 ml water (reagent blank, B1). 0.2 ml standard (S), and 0-2 ml filtered urine (U).
The following were incubated at 37°C with 02 ml acetate buffer (0-1M, pH 5-0), 0*2 ml filtered urine (urine blank, UB), 0.2 ml standard (standard blank, SB). After two hours, the incubation mixtures were centrifuged for 10 minutes at 1600 g, and 50 Iul supernatant was added to 1*2 ml assay reagent; 50 ,ul water was added to 1-2 ml assay reagent. (Reagent Blank, B2).
After five minutes at room temperature, 
COMMENTS
Experiments in which cellobiose was added to urine and subsequently assayed, showed that the measured cellobiose was 96-108% of the amount added. The reproducibility of the overall technique, for calculation of cellobiose/mannitol ratio was 7.5% within batches, and 10.6% between batches. In areas where there is a high incidence of lactase deficiency, sucrose should be used as sole hyperosmolar agent to avoid abdominal discomfort. 
